Research article · 25 Jun 2021
EditorialPublished 24 Feb 2022
An Effective Therapy against SARS-CoV-2
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Commentary · 30 Nov 2020
Early ambulatory multidrug therapy for SARS-CoV-2 (COVID-19) infection.
Short communication · 2022
SARS-CoV-2 and its Focus on Antiviral Therapy
Research article · 14 Apr 2021
A Combo Compound Therapy Effectively Reduces SARS-CoV-1 Viral Load in Mouse Lung
Research article · 8 Feb 2023
Effect of COVID-19 during Pregnancy: Studying the Maternal and Neonatal Outcomes and Assessing the Placental Changes Related to SARS-CoV-2
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Andrew Geller”

